All Infection Prevention & Control articles – Page 13
-
NewsInsights into release of fungal toxin promise progress in treating infections
The toxin Candidalysin of the yeast Candida albicans is incorporated into an unusual protein structure during an infection, and researchers have now succeeded in deciphering the function of this unusual arrangement.
-
NewsNewly identified yeast could prevent fungal infections by outcompeting rivals, study suggests
Researchers have identified a yeast that could be used to prevent invasive candidiasis, a major cause of death in hospitalized and immunocompromised patients.
-
NewsTryptophan in diet and gut bacteria team up to protect against E. coli infection
Gut bacteria and a diet rich in the amino acid tryptophan can play a protective role against pathogenic E. coli, which can cause severe stomach upset, cramps, fever, intestinal bleeding and renal failure, according to a new study.
-
NewsRevolutionary chronic wound treatment could help millions
A team of scientists has developed an effective treatment for preventing infection in chronic wounds involving the plasma (electrical gas) activation of hydrogel dressings to produce a unique mix of different chemical oxidants.
-
NewsStudy shows potential for using AI tools to detect healthcare-associated infections
A new proof-of-concept study reports that artificial intelligence (AI) technologies can accurately identify cases of healthcare-associated infections (HAI) even in complex clinical scenarios.
-
NewsNo persistent cough in 4 out of 5 with tuberculosis
A study of more than 600,000 individuals shows that 80% with TB have no persistent cough, previously believed to be the most common symptom of the infectious disease.
-
NewsStudy reveas how virus hijacks insect sperm to control disease vectors and pests
A new study reveals how viral proteins from symbiotic bacteria cause sterility in insects.
-
NewsLong-acting HIV treatment benefits adults with barriers to daily pill taking and adolescents with suppressed HIV
Long-acting, injectable antiretroviral therapy (ART) suppressed HIV replication better than oral ART in people who had previously experienced challenges taking daily oral regimens and was found safe in adolescents with HIV viral suppression.
-
NewsVaccinated people had lower risk of severe COVID-19 outcomes
Among people who had COVID-19, those who previously received the latest vaccine had a lower risk of having a severe outcome than those who had not, according to new research.
-
NewsChildren surpass a year of HIV remission after treatment pause
Four children have remained free of detectable HIV for more than one year after their antiretroviral therapy (ART) was paused to see if they could achieve HIV remission.
-
NewsCurrent standards for testing wound dressings don’t work for biofilms, study finds
Current standards for testing wound dressings do not work for biofilms, particularly in the case of polymicrobial biofilms, a new study has found. Testing of wound dressings is predominantly carried out on single species of microbes in isolation, even though the wound sterile environment is not sterile and is often ...
-
NewsStudy shows new class of antivirals that works against SARS-CoV-2
Researchers have uncovered a new class of drugs with the potential to prevent or treat infections in a future viral outbreak.
-
NewsMussel-based coating protects joints from bacteria
Scientists have successfully developed a coating material for implants. Based on mussel adhesion proteins, this material is designed to release antibiotics in response to bacterial invasion.
-
NewsResearchers uncover how virus causes cancer, point to potential treatment
Kaposi sarcoma-associated herpesvirus activates a specific pathway to drive viral persistent infection and cell growth, paving the way for tumors to form.
-
NewsResearchers propose ultrasonic power therapy for helicobacter pylori infection
Scientists have developed a nanoparticle-based sonodynamic therapy to reduce H. pylori infection in mice without disrupting gut microbiota.
-
NewsNew antibodies target “dark side” of influenza virus protein
Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored “dark side” of the neuraminidase (NA) protein head.
-
NewsProtective human monoclonal antibody targets a conserved site of spike glycoprotein of SARS-CoV-2 Omicron variants
Scientists report that mAb-39 greatly improved the neutralizing activity of anti-RBD antibody, the same type of EUA therapeutic monoclonal antibodies, against the highly neutralization-resistant Omicron variants.
-
NewsEvidence needed for preventative measures to stop surgical infections
A new research review will look at improving preventive measures to stop surgical infections. It will also ask why we are doing what we are doing, especially when some interventions lack quality evidence to back them.
-
NewsThe future is personalised care for influenza and flu-like illness
A new research review will focus on a future of more personalised care for diseases such as influenza, so that patients and doctors will be able to more accurately determine when the infectious part of the illness has passed.
-
NewsNew approach may prevent deadly intestinal disease in preemies
Scientists have found that an investigational protein replacement protected neonatal mice from necrotizing enterocolitis (NEC), a deadly intestinal disease that often strikes extremely premature infants.
